Revolution Medicines, Inc.

NASDAQ:RVMD

60.44 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q4
Operating Activities:
Net Income -156.288-133.233-116.003-161.537-108.434-98.298-68.098-56.507-73.329-61.222-57.647-52.676-52.94-44.299-37.176-34.204-27.221-27.215-19.519-14.596-12.818-10.119-10.131-11.339
Depreciation & Amortization 0.0662.7972.7632.8582.1451.7732.5332.5992.4332.3342.292.0621.7511.8411.6781.71.631.6711.5440.8650.8730.8110.7930.691
Deferred Income Tax 000-0.043-3.86700-0.41900000000.35900-0.716-4.3730000
Stock Based Compensation 20.77519.77516.20825.42713.66612.989.6998.3168.1388.0986.6446.1975.8275.3133.3872.6322.672.0171.5671.3980.8540.5060.4030.281
Change In Working Capital 51.953-4.74-47.21321.199-2.7321.275-2.949-13.60412.182-4.953-7.1144.2457.7772.371-5.6694.252-4.53.449-11.5050.648-2.542-2.671-4.263-1.61
Accounts Receivables 001.254-0.9452.2011.4850.6780.2670.684-0.2410.5461.483-0.8851.037-1.1712.906-1.9681.1190.2870.213-0.064-0.954-0.629-1.395
Change In Inventory 000-10.946-1.64412.59000003.6012.0881.8670.126-1.33900000000
Change In Accounts Payables -2.788-4.08-28.9624.3050.588.634-1.05-1.50710.239-0.952-0.4922.5730.1891.608-2.1314.616-3.372.143-3.0844.233-0.4721.3060.1970.092
Other Working Capital 54.741-0.66-19.5078.785-3.867-1.434-2.577-12.3641.285-3.76-7.168-3.4126.385-2.141-2.493-1.931-1.131.306-8.421-3.585-2.07-3.977-4.46-1.702
Other Non Cash Items -46.925-12.76633.125-8.467-1.277-4.851-3.576-2.17310.6630.0270.6670.9070.9970.6930.5340.2270.40.0870.6114.406-0.224-0.0290.5930.201
Operating Cash Flow -130.419-128.167-160.56-120.563-100.497-67.121-62.391-61.788-51.737-55.716-55.16-39.265-36.588-34.081-37.246-25.034-27.021-19.991-28.018-11.652-13.857-11.502-12.605-11.776
Investing Activities:
Investments In Property Plant And Equipment -3.52-2.399-3.167-2.317-2.535-1.119-1.758-2.876-3.525-2.526-1.889-1.183-0.454-1.312-3.579-1.169-0.687-0.474-0.603-0.51-1.107-0.631-0.341-0.216
Acquisitions Net 000884.05-79.88742.425-5.7544.2280-64.92700000000000000.16
Purchases Of Investments -364.877-374.855-701.681-519.605-170.039-176.175-193.097-160.335-212.964-127.652-111.818-110.814-168.248-278.235-114.038-44.876-194.052-205.167-100.038-28.584-88.276-55.40600
Sales Maturities Of Investments 346.928485.198456.882141.52249.926133.75198.851156.10793.051192.579157.732120.53138.525156.765119.926108.99193.77269.14540.92537.11129.579000
Other Investing Activites 0110.343-244.799-884.0579.887-42.4255.754-4.228-119.91364.92745.9149.716-29.723-121.475.88864.115-100.28-136.022-59.1130.0040.0050.0856.1020.16
Investing Cash Flow -21.469107.944-247.966-380.40277.352-43.5443.996-7.104-123.43862.40144.0258.533-30.177-122.7822.30962.946-100.967-136.496-59.7168.021-59.799-55.9525.761-0.056
Financing Activities:
Debt Repayment 000000000000000000000000
Common Stock Issued 65.9797.5040.812.5461.01162.053323.70649.919248.1260.4950.30510.0960.319-0.564281.709-0.034167.801-1.417253.717100.0280000.019
Common Stock Repurchased 03.16403.3170001.8640001.8750000.8320-1.3360-0.045000-0.131
Dividends Paid 000000000000000000000000
Other Financing Activities 77.2947.5040.81833.49102.5770.499-0.42248.3350.9340.305-1.2430.3191.4320.5550.6871.0820.0810.027-101.56210.00590.1730.0144.202
Financing Cash Flow 77.2947.5040.81839.3541.01164.63324.20551.363248.3351.4290.30510.7280.3190.868282.2641.485168.883-1.336253.744-1.53410.00590.1730.0144.221
Other Information:
Effect Of Forex Changes On Cash 000-0.6400000000000000000000
Net Change In Cash -74.594-12.719-407.716337.749-22.134-46.035265.81-17.52973.168.114-10.83-20.004-66.446-155.995247.32739.39740.895-157.823166.01-5.165-63.65122.719-6.83-7.611
Cash At End Of Period 204.15278.744288.432696.148360.79382.924428.959163.149180.678107.51899.404110.234130.238196.684352.679105.35265.95525.06182.88316.87322.03885.68962.9769.8